Non-conventional antimicrobial and alternative therapies for the treatment of Clostridium difficile infection

N Roshan, KA Hammer, TV Riley - Anaerobe, 2018 - Elsevier
Clostridium difficile is an anaerobic, Gram-positive, spore-forming bacillus that causes
disease ranging from self-limiting diarrhoea to severe pseudomembranous colitis. C. difficile …

Current Status of Nonantibiotic and Adjunct Therapies for Clostridium difficile Infection

N Suwantarat, DA Bobak - Current infectious disease reports, 2011 - Springer
Clostridium difficile infection (CDI) is a leading cause of nosocomial infections and the most
important cause of health care-associated diarrhea worldwide. Standard treatment of CDI …

[HTML][HTML] Clostridium difficile infection: a review of current and emerging therapies

A Ofosu - Annals of gastroenterology: quarterly publication of the …, 2016 - ncbi.nlm.nih.gov
Clostridium difficile (C. difficile) infection (CDI) is the most common cause of healthcare-
associated infections in US hospitals. The epidemic strain NAP1/BI/ribotype 027 accounts …

Future novel therapeutic agents for Clostridium difficile infection

HL Koo, KW Garey, HL DuPont - Expert opinion on investigational …, 2010 - Taylor & Francis
Importance of the field: Clostridium difficile is the most important definable cause of
healthcare acquired diarrhea. The increasing incidence and mortality associated with this …

Alternative Therapies for Clostridium difficile Infections

C Venuto, M Butler, ED Ashley… - … : The Journal of Human …, 2010 - Wiley Online Library
Clostridium difficile infection is a serious condition responsible for significant morbidity and
mortality, especially in patients being treated with antimicrobials. Increasing frequency of the …

Alternative treatments for Clostridium difficile disease: what really works?

LV McFarland - Journal of medical microbiology, 2005 - microbiologyresearch.org
Vancomycin and metronidazole have been used for treating Clostridium difficile-associated
disease (CDAD) for the past 25 years, but approximately 20% of patients develop recurrent …

New and emerging therapies in treatment of Clostridium difficile infection

H Goyal, A Perisetti, MR Rehman… - European Journal of …, 2018 - journals.lww.com
Clostridium difficile infection (CDI) represents one of the most serious nosocomial infections
that have grown dramatically over the past decade. Vancomycin and metronidazole are …

Clostridium difficile: new therapeutic options

A Balagopal, CL Sears - Current opinion in pharmacology, 2007 - Elsevier
Clostridium difficile disease is the major, known cause of nosocomial diarrhea and is an
emerging cause of community-associated diarrhea. Recent outbreaks due to a strain of …

New and emerging therapies for Clostridium difficile infection

J Martin, M Wilcox - Current opinion in infectious diseases, 2016 - journals.lww.com
New and emerging therapies for Clostridium difficile infecti... : Current Opinion in Infectious
Diseases New and emerging therapies for Clostridium difficile infection : Current Opinion in …

Clostridium difficile infection: an emerging epidemic with more questions than answers

HL DuPont, KW Garey - Future Microbiology, 2010 - Future Medicine
Question 3. How should we diagnose CDI? With the rising prevalence and severity of CDI,
there has been a renewed interest in accurate and rapid diagnosis. Many diagnostic …